These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35600209)

  • 21. Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease.
    Sartini A; Gitto S; Bianchini M; Verga MC; Di Girolamo M; Bertani A; Del Buono M; Schepis F; Lei B; De Maria N; Villa E
    Cell Death Dis; 2018 Jan; 9(2):87. PubMed ID: 29367619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of nonalcoholic fatty liver disease on inflammatory bowel disease-related hospitalization outcomes: a systematic review.
    Boustany A; Rahhal R; Mitri J; Onwuzo S; Abou Zeid HK; Baffy G; Martel M; Barkun AN; Asaad I
    Eur J Gastroenterol Hepatol; 2023 Oct; 35(10):1067-1074. PubMed ID: 37577829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease.
    Gibiino G; Sartini A; Gitto S; Binda C; Sbrancia M; Coluccio C; Sambri V; Fabbri C
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Lin A; Roth H; Anyane-Yeboa A; Rubin DT; Paul S
    Inflamm Bowel Dis; 2021 May; 27(6):947-955. PubMed ID: 32780094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
    Bosch DE; Yeh MM
    Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article.
    Chao CY; Battat R; Al Khoury A; Restellini S; Sebastiani G; Bessissow T
    World J Gastroenterol; 2016 Sep; 22(34):7727-34. PubMed ID: 27678354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study.
    Adams LC; Lübbe F; Bressem K; Wagner M; Hamm B; Makowski MR
    PLoS One; 2018; 13(11):e0206450. PubMed ID: 30427909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.
    Dhamija E; Paul SB; Kedia S
    Indian J Med Res; 2019 Jan; 149(1):9-17. PubMed ID: 31115369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis.
    Hoffmann P; Jung V; Behnisch R; Gauss A
    World J Gastroenterol; 2020 Dec; 26(46):7367-7381. PubMed ID: 33362390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE.
    Virović Jukić L; Grgurević I; Mikolašević I; Filipec Kanižaj T; Milić S; Mrzljak A; Premužić M; Hrstić I; Knežević-Štromar I; Ljubičić N; Ostojić R; Stojsavljević Shapeski S; Amerl-Šakić V; Marković NB; Rađa M; Soldo D; Sobočan N; Lalovac M; Puljiz Ž; Podrug K; Ladić D
    Acta Clin Croat; 2021 Dec; 60(Suppl 2):36-52. PubMed ID: 35528151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Jeon Y; Limketkai BN
    Dig Dis Sci; 2021 Sep; 66(9):2853-2854. PubMed ID: 33089485
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
    Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins.
    Lucero D; Miksztowicz V; Gualano G; Longo C; Landeira G; Álvarez E; Zago V; Brites F; Berg G; Fassio E; Schreier L
    Clin Chim Acta; 2017 Oct; 473():1-8. PubMed ID: 28802640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice.
    Zhou ST; Cui W; Kong L; Yang X
    Curr Med Sci; 2022 Jun; 42(3):513-519. PubMed ID: 35451807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
    Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
    Johnston MP; Patel J; Byrne CD
    Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.